Figure 3From: Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in ratsCorrelation between PPARγ agonist GI262570 (0.2–100 mg/kg)-elevated serum adiponectin and GI262570-decreased serum insulin, triglycerides, free fatty acids, and insulin AUC during OGTT in HF fed SD rats.Back to article page